Lv7
4980 积分 2021-08-21 加入
Randomized Phase II Trial of Immunotherapy-Based Total Neoadjuvant Therapy for Proficient Mismatch Repair or Microsatellite Stable Locally Advanced Rectal Cancer (TORCH)
1小时前
待确认
Short-course-based TNT with or without PD-1 inhibitor for pMMR locally advanced rectal cancer: Phase 2 results of a randomized trial (STELLAR II)
1小时前
待确认
ESMO–ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitors
1个月前
已完结
Beyond the Guided Missile Paradigm: Embracing the Complexity of Antibody-Drug Conjugates
3个月前
已完结
皖公网安备34019202002308
